Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Jun
13
2016
Merck’s Solvaldi® Patents Unenforceable for Egregious Misconduct Schwegman, Lundberg & Woessner, P.A.
Mar
25
2020
China-Norway Patent Prosecution Highway (PPH) Pilot to Start April 1, 2020 Schwegman, Lundberg & Woessner, P.A.
May
9
2014
Section 101 Fells Dolly: What Organism Is Next? Adult Cell Cloning. Schwegman, Lundberg & Woessner, P.A.
Apr
13
2020
Beijing Fines Alibaba for Malicious Registration of Coronavirus Chinese Trademarks Schwegman, Lundberg & Woessner, P.A.
Apr
28
2020
Beijing Treaty on Audiovisual Performances Comes into Force in China Today, April 28, 2020 Schwegman, Lundberg & Woessner, P.A.
Aug
14
2020
AAM v. Neapco – Part IV – Petition for Rehearing En Banc Denied – “Bad Vibrations” Schwegman, Lundberg & Woessner, P.A.
Sep
13
2020
China’s Supreme People’s Court Releases Provisions on Several Issues Concerning the Application of Law in Trial of Civil Cases of Infringement of Trade Secrets Schwegman, Lundberg & Woessner, P.A.
Oct
18
2020
China’s National People’s Congress Approves Amended Patent Law Schwegman, Lundberg & Woessner, P.A.
Aug
25
2014
Takeaways from Seattle Chisum Patent Academy Summer 2014 Seminars Schwegman, Lundberg & Woessner, P.A.
Nov
4
2020
China’s State Administration for Market Regulation Releases Updated Regulations on Prohibiting Abuse of Intellectual Property Rights to Exclude and Restrict Competition Schwegman, Lundberg & Woessner, P.A.
Nov
17
2020
Prosecution Guidance from the Fed. Cir. – How to Forfeit Arguments During Your Appeal Schwegman, Lundberg & Woessner, P.A.
Nov
20
2020
NavInfo Awarded 64.5 Million RMB in Chinese Copyright Infringement Lawsuit Against Baidu Schwegman, Lundberg & Woessner, P.A.
Dec
26
2020
China to Allow Foreign Patent Firms to Open in 3-Year Pilot Program Schwegman, Lundberg & Woessner, P.A.
Jan
29
2021
Casio Awarded 8.8 Million RMB in Chinese Design Patent Infringement Case for Watches Schwegman, Lundberg & Woessner, P.A.
Oct
9
2014
European Patent Office (EPO) – New Guidance On Added Subject Matter Schwegman, Lundberg & Woessner, P.A.
Feb
26
2021
China’s Supreme People’s Court Awards 159 Million RMB Compensation in Vanillin Trade Secret Case Schwegman, Lundberg & Woessner, P.A.
Mar
3
2021
China’s Supreme People’s Court Issues Law Interpretation for Intellectual Property Infringement Schwegman, Lundberg & Woessner, P.A.
Mar
20
2021
China’s Supreme People’s Court Releases Typical Cases of Punitive Damages in Intellectual Property Infringement Schwegman, Lundberg & Woessner, P.A.
Apr
21
2021
Legal Digital Transformation – Lesson #3: Successful Digital Transformation Depends on Excellent Interoperability of All IP Systems Schwegman, Lundberg & Woessner, P.A.
May
10
2021
China’s National Intellectual Property Administration Starts Blocklist for Malicious Trademark Applicants Schwegman, Lundberg & Woessner, P.A.
Jul
5
2017
Cleveland Clinic v. True Health Diagnostics – Time to Redefine “Inventive Concept”? Schwegman, Lundberg & Woessner, P.A.
May
28
2021
China Releases Administrative Adjudication Measures for Major Patent Infringement Disputes Effective June 1, 2021 Schwegman, Lundberg & Woessner, P.A.
Jun
13
2021
China To Reduce Stamp Tax on Intellectual Property Transactions Schwegman, Lundberg & Woessner, P.A.
Jun
23
2021
China National Intellectual Property Administration to Give Priority to Patent Invalidation Cases Involved in Concurrent Litigation Schwegman, Lundberg & Woessner, P.A.
Feb
20
2015
Pacing Technologies v. Garmin – D&D Explained Schwegman, Lundberg & Woessner, P.A.
Sep
24
2021
World Intellectual Property Organization Releases Global Innovation Index 2021 – China Edges Closer to Top 10 Schwegman, Lundberg & Woessner, P.A.
Mar
9
2015
Novartis Wins Landmark Biosimilar Approval Schwegman, Lundberg & Woessner, P.A.
Mar
12
2015
Eidos Display, LLC v. AU Optronics Corp: Claim Definite Enough for those of Skill in the Art, even if Not the Eastern District of Texas Schwegman, Lundberg & Woessner, P.A.
Oct
26
2021
Zhejiang, China Fines Hangzhou Patent Firm for Not Withdrawing 164 Abnormal Patent Applications and Suspicion of Filing 1,192 Abnormal Applications in Total Schwegman, Lundberg & Woessner, P.A.
Nov
5
2021
Johnson & Johnson Medical Devices Companies Gets Patent Infringement Damages Upped 20X at China’s Supreme People’s Court Schwegman, Lundberg & Woessner, P.A.
Nov
12
2021
China to Revoke Patent Agencies’ Licenses for Filing Abnormal Patent Applications Schwegman, Lundberg & Woessner, P.A.
Apr
5
2011
Federal Court Hears Myriad Gene Case This Morning Schwegman, Lundberg & Woessner, P.A.
Apr
18
2011
Walker Digital Files 15 Patent Suits Against More Than 100 Companies Schwegman, Lundberg & Woessner, P.A.
Feb
2
2022
China’s National Intellectual Property Administration Releases 2021 Results for the Blue Sky IP Agency Rectification Campaign Schwegman, Lundberg & Woessner, P.A.
Apr
26
2011
Can Post Grant Review Enhance Patent Quality? Schwegman, Lundberg & Woessner, P.A.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins